You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Merck
Mallinckrodt
AstraZeneca
Colorcon
Baxter
Moodys

Last Updated: August 13, 2020

DrugPatentWatch Database Preview

MEDROXYPROGESTERONE ACETATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Medroxyprogesterone Acetate, and when can generic versions of Medroxyprogesterone Acetate launch?

Medroxyprogesterone Acetate is a drug marketed by Amphastar Pharms Inc, Cipla, Mylan Labs Ltd, Sandoz Inc, Sun Pharm, Teva Pharms Usa, Barr, Duramed Pharms Barr, and Upsher Smith Labs. and is included in twelve NDAs.

The generic ingredient in MEDROXYPROGESTERONE ACETATE is medroxyprogesterone acetate. There are twenty drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the medroxyprogesterone acetate profile page.

US ANDA Litigation and Generic Entry Outlook for Medroxyprogesterone Acetate

A generic version of MEDROXYPROGESTERONE ACETATE was approved as medroxyprogesterone acetate by BARR on August 9th, 1996.

  Start Trial

Drug patent expirations by year for MEDROXYPROGESTERONE ACETATE
Drug Prices for MEDROXYPROGESTERONE ACETATE

See drug prices for MEDROXYPROGESTERONE ACETATE

Recent Clinical Trials for MEDROXYPROGESTERONE ACETATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Centre Hospitalier Intercommunal CreteilPhase 3
Nationwide Children's HospitalPhase 4
Ohio State UniversityPhase 4

See all MEDROXYPROGESTERONE ACETATE clinical trials

Pharmacology for MEDROXYPROGESTERONE ACETATE
Drug ClassProgestin
Medical Subject Heading (MeSH) Categories for MEDROXYPROGESTERONE ACETATE

US Patents and Regulatory Information for MEDROXYPROGESTERONE ACETATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amphastar Pharms Inc MEDROXYPROGESTERONE ACETATE medroxyprogesterone acetate INJECTABLE;INJECTION 077235-001 Nov 28, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Sun Pharm MEDROXYPROGESTERONE ACETATE medroxyprogesterone acetate INJECTABLE;INJECTION 210761-001 Apr 24, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Mylan Labs Ltd MEDROXYPROGESTERONE ACETATE medroxyprogesterone acetate INJECTABLE;INJECTION 210227-001 Oct 12, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Barr MEDROXYPROGESTERONE ACETATE medroxyprogesterone acetate TABLET;ORAL 040159-003 Aug 9, 1996 AB RX No No   Start Trial   Start Trial   Start Trial
Teva Pharms Usa MEDROXYPROGESTERONE ACETATE medroxyprogesterone acetate INJECTABLE;INJECTION 076552-001 Oct 27, 2004 DISCN No No   Start Trial   Start Trial   Start Trial
Upsher Smith Labs MEDROXYPROGESTERONE ACETATE medroxyprogesterone acetate TABLET;ORAL 088484-001 Jul 26, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Medtronic
Dow
Mallinckrodt
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.